INTRODUCTION
============

Back pain accounts for more than half of all musculoskeletal disabilities, making it one of the most prevalent and costly medical conditions ([@b31-0050073]; [@b18-0050073]; [@b35-0050073]). The most common cause of back pain is disc degeneration, the etiology of which is poorly defined, making it difficult to distinguish from the physiological processes of growth, aging or adaptive remodeling ([@b2-0050073]). Disc degeneration has perhaps best been defined as an aberrant, cell-mediated response to progressive structural failure ([@b2-0050073]): a cascade beginning with changes to the cellular microenvironment within the disc that progresses over decades resulting in structural breakdown and functional impairment ([@b40-0050073]). Degeneration of the intervertebral disc (IVD) is characterized by increased extracellular matrix breakdown, abnormal (fibrotic) matrix synthesis, inflammation, and in-growth of nociceptive nerves and blood vessels into a typically aneural and avascular tissue. Although the exact cause(s) of disc degeneration are unclear, initiation and progression of the degenerative cascade involve multiple interdependent factors, including altered mechanical loading ([@b33-0050073]), reduction in nutrient supply ([@b46-0050073]), altered cellular composition ([@b3-0050073]) and hereditary factors ([@b22-0050073]; [@b48-0050073]; [@b5-0050073]). Currently, there is no effective disease-modifying treatment for individuals with this disease who develop persistent pain.

The IVD is a specialized connective tissue structure consisting of three distinct yet interdependent tissues: the outer fibrillar annulus fibrosus (AF), the central viscous nucleus pulposus (NP) and the cartilage end-plates (CEPs; which anchor the discs to the adjacent vertebral body bones). The NP is composed of a proteoglycan and water gel held together loosely by an irregular network of type II collagen and elastin fibers. The major proteoglycan of the disc is aggrecan, which, owing to its highly anionic glycosaminoglycan content, provides the osmotic properties enabling the NP to maintain height and turgor against compressive loads ([@b51-0050073]; [@b2-0050073]; [@b39-0050073]). The NP contains two distinct cell types: large clusters of notochordal cells and smaller, more disperse cartilage-like cells ([@b36-0050073]). Interestingly, the loss of notochordal cells is associated with the onset of disc degeneration, suggesting that these cells are required for the maintenance of the NP ([@b3-0050073]; [@b8-0050073]; [@b20-0050073]).

Although the role of the notochord during gastrulation has been extensively studied ([@b7-0050073]), the function of the notochord during IVD formation remains relatively unknown. In the early mouse embryo, the node is formed at embryonic day 7.5 (E7.5) and is the source of cells that will form the rod-like structure of the notochord ([@b52-0050073]). The notochord is an important source of signals for patterning of the developing embryo, specifically axis determination in both dorso-ventral and left-right planes ([@b21-0050073]; [@b7-0050073]; [@b6-0050073]). The vertebral column is formed by aggregation of the somatic mesenchyme around the notochord, forming a continuous perichordal tube that undergoes segmentation at E13.5 to form condensed and non-condensed regions that give rise to the vertebrae and IVDs, respectively ([@b13-0050073]; [@b47-0050073]). Within the IVD, notochordal cells proliferate and accumulate a gelatinous, glycosaminoglycan-rich extracellular matrix, which separates the original cell mass into a network of small cell clusters. The NP becomes surrounded by the mesenchyme-derived AF ([@b12-0050073]; [@b14-0050073]) ([Fig. 1](#f1-0050073){ref-type="fig"}).

Beginning as early as the second decade of life in humans, notochordal cells are no longer detected within the NP, which is populated instead by smaller more disperse cartilage-like cells ([@b10-0050073]; [@b53-0050073]). Currently, identification of these two cell types is restricted to cell morphology analysis and use of a limited number of notochord-specific markers ([@b15-0050073]; [@b17-0050073]; [@b29-0050073]). There have historically been two conflicting hypotheses regarding the origin of the cartilage-like cells of the NP. It was originally suggested that these cells were of mesenchymal origin, a consequence of the migration of cells to the NP from the surrounding CEP ([@b50-0050073]). During tissue formation, notochordal cells were believed to direct mesenchymal cell migration, stimulate matrix synthesis and, upon completion of their role, undergo apoptosis or necrosis ([@b44-0050073]; [@b24-0050073]). Alternatively, it has been suggested that notochordal cells are progenitors for all NP cells, and undergo terminal differentiation to give rise to chondrocyte-like cells ([@b34-0050073]; [@b8-0050073]; [@b27-0050073]). In these two scenarios, notochordal cells play distinct roles, that of organizer and tissue-specific progenitor, respectively. Although recent studies sought to address this longstanding debate and suggested that NP cells are derived from the embryonic notochord, technical limitations prevented a definitive conclusion regarding cell fate ([@b11-0050073]).

To clearly define the developmental origins of the NP, we have targeted the gene encoding the notochord-specific transcription factor *Noto* to generate a mouse line expressing Cre recombinase specifically in the notochord. *Noto* is a highly conserved homeobox transcription factor whose expression is restricted to the organizer node and the nascent notochord during gastrulation and axis elongation (E7.5--E12.5); here, it regulates node morphogenesis, notochord ciliogenesis and left-right patterning ([Fig. 1A,B](#f1-0050073){ref-type="fig"}) ([@b1-0050073]; [@b52-0050073]; [@b54-0050073]). Expression of *Noto* is detected at E7.5 within the ventral node, with the onset of primitive streak formation. Between E8.0 and E9.0, *Noto* is expressed in the node and newly formed notochord but not in the anterior node or mature notochord. *Noto* expression is restricted to the notochordal plate and posterior notochord until E12.5, after which its expression is no longer detected ([@b1-0050073]). Using this novel notochord-specific Cre mouse, we provide evidence that all cells present within the NP, from tissue formation through to skeletal maturity, are of notochord origin.

![**Schematic representation of the main stages in axial skeletogenesis.** (A) Formation of the node (N) and elongation of the notochord (NC). LPM, lateral plate mesoderm; PXM, paraxial mesoderm. (B) Aggregation of the somatic mesenchyme around the notochord leads to formation of a continuous perichordal tube (PT). Localization of *Noto* expression at these time points is indicated in green. (C) Condensation of the axial mesenchyme leads to spine segmentation and perichordal disc formation. AF, annulus fibrosis; VB, vertebral bodies. (D) Formation of intervertebral discs (IVDs) is associated with the disappearance of the notochord within the vertebral bodies, and its expansion within the IVD. CEP, cartilage end-plates; NP, nucleus pulposus.](DMM008128F1){#f1-0050073}

RESULTS
=======

The *Noto*-*cre* allele was created by knocking the site-specific recombinase gene *cre* into exon 2 of the *Noto* locus ([Fig. 2A](#f2-0050073){ref-type="fig"}). Using this strategy, *cre* is expressed in all *Noto*-expressing cells, specifically in the node and posterior notochord between E7.5 and E12.5 ([@b52-0050073]), and in all of their descendents. To ensure that the temporal regulation of *Noto* expression was not altered in our transgenic strain, in situ hybridization was performed. In both *Noto^cre/+^* and wild-type littermate controls (*Noto*^+/+^), *Noto* expression was detected in the posterior notochord at E11.5 ([Fig. 2B](#f2-0050073){ref-type="fig"}) and was undetectable by E15.5 ([Fig. 2C](#f2-0050073){ref-type="fig"}).

Previous studies demonstrated that homozygous disruption of the *Noto* gene leads to embryonic or early postnatal lethality, but heterozygous animals are viable with no reported phenotype ([@b1-0050073]; [@b6-0050073]; [@b52-0050073]). To ensure that heterozygous inactivation of *Noto* did not alter notochord formation or IVD development, spine segments from *Noto^cre/+^* mice were assessed by histology at postnatal day 21 (P21) and compared with wild-type littermate controls (*Noto*^+/+^). Examination of tissue architecture and joint formation by Safranin-O/Fast Green staining demonstrated no alterations in notochord structures or IVD formation in *Noto^cre/+^* mice ([Fig. 2D](#f2-0050073){ref-type="fig"}). Therefore, all subsequent studies were conducted using the heterozygous *Noto^cre/+^* mouse to interrogate IVD formation.

![**Generation of the notochord-specific Cre mouse line.** (A) Targeting strategy used to generate the *Noto^cre/+^* line. An internal ribosome entry site-nuclear localization signal-Cre recombinase (IRES-NLS-CRE) cassette replaced exon 2 of the *Noto* locus. Positively targeted ES cell clones were confirmed by Southern blot using an external 5′ probe; the wild-type allele is 15 kb and the targeted allele is 10 kb. Representative positive 'neo-in' clones are shown. The positions of genotyping PCR primers for wild-type and 'neo-out' mice are also shown. (B) Targeting of the *Noto* locus does not affect its temporal regulation, as demonstrated by whole mount in situ hybridization at E11.5. *Noto* expression is detected in both *Noto^cre/+^* and wild-type (*Noto^+/+^*) littermate control embryos, localized to the posterior node in the tail region (insert and arrows). (C) *Noto* expression is downregulated after E12.5, confirmed by in situ hybridization at E15.5 showing no detectable *Noto* expression. (D) Heterozygous inactivation of *Noto* does not disrupt notochord formation or IVD development. IVD formation and tissue architecture was examined in *Noto^cre/+^* mice and wild-type (*Noto^+/+^*) littermate controls using Safranin-O/Fast Green staining on paraffin embedded sections at P21. Enlarged view of the NP and inner AF tissues are shown in the right-hand box. Scale bars: 500 μm for 100× images and 50 μm for 400× images.](DMM008128F2){#f2-0050073}

Through mating with the conditional *Rosa26* (*R26*)*-lacZ* reporter \[*Gt(ROSA)26Sor^tm1so^*\] ([@b41-0050073]), fate mapping studies were conducted. Embryos carrying both the *Noto-cre* allele and the *R26-lacZ* reporter showed specific β-galactosidase expression in a subset of node and notochordal cells at E8.0, the stage at which the node is reported to undergo elongation to form the notochord ([Fig. 3A,B](#f3-0050073){ref-type="fig"}). The mouse notochord has previously been reported to form in a non-sequential pattern with multiple organizing centers ([@b52-0050073]). A discontinuous pattern of *Noto* expression was observed at E8.5, in which different centers of notochord formation were seen along the rostro-caudal axis ([Fig. 3C,D](#f3-0050073){ref-type="fig"}). These centers ultimately connected to form the solid rod-like notochord by E10.5 ([Fig. 3E,F](#f3-0050073){ref-type="fig"}).

The segmentation of the notochord can be seen at E15.5 and E17.5 ([Fig. 3G--M](#f3-0050073){ref-type="fig"}). Owing to opacity of embryos at these later developmental stages, the staining protocol was modified to include an embryo clearing step that renders the embryo translucent while leaving the β-galactosidase stain intact ([@b38-0050073]). β-galactosidase expression within the IVD was observed in the upper thoracic region of the embryo, flanked by developing vertebrae ([Fig. 3L](#f3-0050073){ref-type="fig"}). The formation of the NP through notochord condensation and segmentation was seen throughout the embryonic time points, originating caudally and proceeding rostrally. This was evident in the tail region at E15.5, where the nuclei pulposi remain connected via the remaining notochord ([Fig. 3J](#f3-0050073){ref-type="fig"}, arrow).

At postnatal time points, β-galactosidase expression was detected throughout the thoracic spine to caudal tip of the tail ([Fig. 4](#f4-0050073){ref-type="fig"}). Small clusters of notochordal cells were detected that were not incorporated into the NP of the IVD but seemed instead to form notochord remnants (also known as intraosseous benign notochordal cell tumors) within the vertebral bone ([Fig. 4B](#f4-0050073){ref-type="fig"}). These notochord remnants were indiscriminately localized throughout the spine at postnatal time points, and were present in \>90% of spines examined. In order to more accurately localize β-galactosidase expression to specific cellular components of the IVD, tissues were examined by histology. Cryosections were performed on skeletally mature mice (P100) in order to preserve β-galactosidase staining. β-galactosidase was localized specifically to the NP, with no stain present in the surrounding AF or CEPs ([Fig. 4C](#f4-0050073){ref-type="fig"}).

To examine β-galactosidase expression within specific cell types of the NP, paraffin-embedded IVD samples were examined by immunohistochemistry for expression of β-galactosidase and cytokeratin-8, a commonly used marker of notochordal cells ([@b17-0050073]) ([Fig. 5](#f5-0050073){ref-type="fig"}). Within the newly formed IVD (E15.5), cells demonstrated a physaliferous appearance characteristic of notochordal cells and expressed both β-galactosidase and cytokeratin-8 ([Fig. 5A,B](#f5-0050073){ref-type="fig"}). In postnatal life, the NP underwent a dramatic change in cellular composition and became progressively populated by cartilage-like NP cells which seemed to be smaller than notochordal cells and were surrounded by pericellular extracellular matrix ([Fig. 5C](#f5-0050073){ref-type="fig"}). We therefore examined the NP at 9 months to determine the contribution of the notochord to this heterogeneous population. At this stage, all cells were positive for β-galactosidase, while only a subset of cells maintained cytokeratin-8 colocalization ([Fig. 5D](#f5-0050073){ref-type="fig"}). The detection of β-galactosidase in the chondrocyte-like NP cells demonstrated that they are derived from the embryonic notochord.

![**Whole-mount examination of β-galactosidase staining in** ***Noto**^cre/+^**;R26**^R/+^*** **embryos.** (A--M) Staining pattern of β-galactosidase, demonstrating the localization of notochord-derived cells throughout embryonic development (stages indicated). Higher-magnification view of β-galactosidase expression at each respective time point is presented in panels to the right. Arrows denote positive β-galactosidase staining at each embryonic stage. (I--M) β-galactosidase expression in E15.5 and E17.5 embryos, rendered clear to enable tissue visualization, shows expression within IVDs in the developing spine. Asterisks (\*) indicate non-specific background staining; specificity of Cre expression was confirmed by comparing background staining in *Noto^+/+^* littermate controls (data not shown). Scale bars: 1 mm.](DMM008128F3){#f3-0050073}

![**β-galactosidase staining at postnatal time points in** ***Noto**^cre/+^**;R26**^R/+^*** **mice.** (A,B) P100 skeletally mature murine spine;β-galactosidase staining was present from the tail to the upper thoracic spine. Arrows indicate positive β-galactosidase staining in the IVD; arrowhead denotes notochord remnant cells within the vertebral bone, which go on to form intraosseous benign notochordal cell tumors. (C) At P100, β-galactosidase staining was evident throughout the NP, whereas the AF was negative. Representative 30 μm sagittal cryosection of an IVD stained for β-galactosidase is shown (originally from tail region in B).](DMM008128F4){#f4-0050073}

DISCUSSION
==========

Our ability to demonstrate the fate and function of notochordal cells within the IVD has thus far been limited. A key tool for understanding cell function in model organisms is the Cre-*loxP* system for conditional mutagenesis ([@b25-0050073]). This approach can be extremely informative when carefully selected Cre recombinase lines are paired with *loxP*-flanked conditional reporter genes. Although notochord-expressing Cre mouse lines have been generated using elements from the *Foxa2* and *Nodal* genes, Cre expression was also detected in the ventral neural tube, or floor plate, and the definitive endoderm in these lines ([@b42-0050073]; [@b45-0050073]). By contrast, expression of the homeobox gene *Noto* is restricted to the node and the posterior notochord during gastrulation (E7.5--E12.5) and is not detected in the notochord or derivative structures after this stage ([@b49-0050073]; [@b42-0050073]; [@b43-0050073]). Furthermore, *Noto*-*GFP* knock-in permitted analysis of notochord formation and morphogenesis during gastrulation ([@b52-0050073]). We therefore targeted the *Noto* locus to generate a Cre knock-in mouse (*Noto-cre*) and provide considerable evidence that the notochord acts as the embryonic precursor of all cells found within the mature NP. We demonstrate that all cells within the NP, both the large notochordal cells as well as the smaller chondrocyte-like NP cells, are of notochordal origin.

Our results are consistent with a previous study by Choi and colleagues that used an inducible *Shh-cre^ERT2^* system to mark the notochord during development ([@b11-0050073]). The *Shh-cre^ERT2^* system does have certain limitations; for example, *Shh* is expressed in the notochord as well as in many other cell types in the early embryo ([@b9-0050073]; [@b28-0050073]), making it difficult to definitively track lineages at later stages. Also, the tamoxifen that is injected into pregnant mice for induction of *cre^ERT2^* in utero can persist for up to 48 hours, which could potentially lead to Cre induction in any *Shh*-expressing cells during that time window. Our model demonstrates that *Noto*-expressing notochordal cells give rise to all cells within the mature NP. Consistent with these findings, recent studies examining the gene expression profile of specific IVD cell populations in bovine samples reported a common gene expression signature in notochordal and NP cells that was not detected in articular chondrocytes (including brachyury and cytokeratins 8, 18 and 19), and suggested that this resulted from a common lineage ([@b29-0050073]). Furthermore, studies using rabbit-derived cells demonstrated the ability of notochordal cells to undergo directed in vitro differentiation, producing cells that are morphologically and phenotypically similar to chondrocyte-like NP cells ([@b23-0050073]).

Initially, the *floating head* (*flh*) gene was identified in zebrafish and was found to encode a homeodomain protein that was essential for notochord formation along the body axis ([@b43-0050073]). Orthologs of *flh* were found in *Xenopus* and chicks, and were named *Not* genes. The mammalian equivalent was identified with the report of an autosomal recessive mutation in mice that disrupted development of the caudal notochord ([@b1-0050073]). The *Not* gene was renamed *Noto* in mammals and has been shown to be involved in axis patterning, notochord ciliogenesis, and node and tail bud morphogenesis ([@b6-0050073]; [@b30-0050073]). It was the highly specific nature of *Noto* that made it an ideal tool to track the notochord, and it is for that reason that we generated a the *Noto-cre* mouse. Given that the *Noto* transcript is detected only in the node and posterior notochord ([@b52-0050073]), we initially suspected that *Noto-cre* expression was going to be limited to the posterior region of the spine. Our results, however, show that *Noto-cre* is detected in the tail but also throughout the axial spine to the upper thoracic region, thereby demonstrating the potential of this mouse to explore the phenotype and function of notochordal cells during development and in postnatal life, including the generation of notochord-specific gene knockouts.

![**Colocalization of β-galactosidase and cytokeratin-8 in the NP.** (A) Representative hematoxylin and eosin (H&E)-stained sections of IVDs at E17.5 (tail region). Cells within the NP demonstrate characteristic physaliferous morphology associated with notochordal cells (arrowhead), and are surrounded by embryonic mesenchyme. (B) Immunolocalization of β-galactosidase (green) and cytokeratin-8 (red) expression. No cytokeratin-8-negative cells were detected at this stage, suggesting that all cells maintain a notochord phenotype. Lower panels are a magnified view of each respective panel above. (C) Representative H&E-stained sections of a 9-month-old mouse lumbar disc demonstrates the heterogeneous cellular composition of the mature NP. (D) Colocalization of β-galactosidase (green) and cytokeratin-8 (red) in serial sections demonstrates that, although all cells are β-galactosidase positive, only a subset of cells maintain cytokeratin-8 expression (100×, 200× and 400× scale bars are 100 μm, 100 μm and 50 μm, respectively).](DMM008128F5){#f5-0050073}

By mating *Noto-cre* mice with the conditional *R26-lacZ* reporter mouse, these studies have traced cells of notochord origin during the dynamic process of notochord formation, elongation, condensation and eventual formation of the NP within the IVD. We demonstrate that notochord segmentation and NP formation proceeds in the rostral-to-caudal direction, as can be seen in the tail region of E15.5 and E17.5 mice. At these stages, notochord-derived cells are localized within fully formed IVDs in the thoracic region, while in the tail the notochord remains connected to the condensed regions that will form the NP.

Interestingly, during the early stage of notochord formation and elongation (E8.0), *cre* expression did not seem to be uniform throughout the notochord, and was instead detected in distinct cell clusters or centers. This heterogeneous pattern of notochord formation has previously been reported using *Noto*-driven reporters (i.e. *Noto^eGFP^*) ([@b1-0050073]; [@b52-0050073]) as well as other node and notochord enhancer transgenics ([@b32-0050073]; [@b37-0050073]). In the current study, this patchy expression was however resolved at later stages of development (E17.5), when β-galactosidase expression was detected throughout the notochord, suggesting that the heterogeneous nature of the early notochord is not an artifact of our system. We suggest instead that the heterogeneity often observed in the notochord is biologically significant. It might be that mesodermal cells can be incorporated into the notochord and then differentiate via interaction with their neighbors. This has been observed in transplantation of zebrafish *Noto* (*flh*) mutant cells to wild-type hosts -- these cells lack a gene that is crucial for notochord formation, yet they can still incorporate and contribute to the notochord ([@b4-0050073]). Future studies will be needed to determine the exact cause of heterogeneous expression in various notochord transgenic lines.

Speculations regarding the developmental origins of the heterogeneous population of cells that constitute the mature NP have argued that the cartilage-like cells originate either from the notochord, or from the surrounding mesenchyme following migration of cells to the NP from the adjacent CEPs or inner AF. We present evidence that notochordal cells are the precursor cells of the NP, and undergo differentiation to generate chondrocyte-like cells during postnatal development. This transition might be induced by a variety of factors present in the extracellular environment of the IVD. Most notably, with aging the nutrient supply to the already avascular and hypoxic NP becomes increasingly limited owing to calcification of the end-plates ([@b46-0050073]). The resulting changes in oxygen, glucose and lactic acid concentration within the NP might contribute to terminal notochordal cell differentiation to chondrocyte-like cells.

The lack of effective biological treatment for the widespread clinical problem of IVD degeneration is directly related to our limited understanding of the mechanisms regulating the processes of disc development, maintenance and degeneration. This gap in our knowledge is due to an incomplete understanding of the specific phenotypes of IVD cell types and the relative importance of the individual growth factors, secreted molecules and matrix components that constitute the unique extracellular environment of the IVD. Given its role in maintaining the physiological function of the IVD, a more complete understanding of notochord and NP biology is of vital importance. The described notochord-specific Cre mouse model will be a valuable tool in future studies to interrogate the function of candidate regulatory molecules during the processes of IVD development, homeostasis and degeneration, with the eventual goal of identifying candidate biological treatments for disc degeneration.

In summary, this report provides evidence demonstrating the notochord origin of all cells within the NP and demonstrates the potential of the *Noto-cre* mouse in understanding IVD biology.

METHODS
=======

Generation of the notochord-specific *Noto-cre* mouse strain
------------------------------------------------------------

All experiments were performed under Institutional Animal Care and Use Committee guidelines at The University of Western Ontario and Toronto Centre for Phenogenomics. To generate the *Noto-cre* knock-in mouse, the *Noto* targeting vector was amplified using long-range PCR (Roche HiFi Taq polymerase) from a BAC clone that contained the *Noto* locus (RP23-417O15; library derived from female C57BL/6J tissues). PCR primers added *Eco*RI and *Not*I sites to the 5′ and 3′ homology arms, respectively (sequence provided in [Table 1](#t1-0050073){ref-type="table"}). The 3′ homology arm PCR product (∼3 kb) was ligated into a pICN vector, and confirmed by restriction digest and sequencing. The pICN vector contains an IRES-NLS-CRE cassette (generously provided by Andras Nagy, Samuel Lunenfeld Research Institute, Toronto, Canada) arranged as follows: *Eco*RI-IRES-NLS-CRE-FRT-PGK-NEO-FRT-*Not*I/*Sac*I. The 5′ homology arm PCR product (∼5 kb) was digested with *Eco*R1, ligated into the pICN-*Noto*-3′ vector, and confirmed by restriction digest and sequencing.

The final p*Noto*-5′-ICN-*Noto*-3′ plasmid was linearized and electroporated in G4 embryonic stem (ES) cells ([@b16-0050073]) using standard protocols. After neomycin selection, ∼170 colonies were screened by Southern blot. A 5′ external probe was isolated from a plasmid generously shared by Anja Beckers and Achim Gossler ([@b1-0050073]) and used to confirm positively targeted clones ([Fig. 2A](#f2-0050073){ref-type="fig"}). Ten of ∼120 clones were positive, giving a targeting efficiency of ∼8%. Two independent positive ES cell clones were used to produce founder chimeras. Both clones produced chimeras and were crossed to CD1 (ICR) for germline transmission. Positive F1 mice were confirmed by Southern blot, and crossed to a FLPe deleter strain \[MGI Strain: B6;SJL-Tg(ACTFLPe)9205Dym/J\] for recombination between FRT sites and removal of PGK-NEO.

Genotyping of mice
------------------

Mice were genotyped by PCR analysis using ear clipping DNA samples and *Noto-cre* knock-in was confirmed by PCR genotyping using the *Noto* wild-type (WT) and 'neo-out' primers (location indicated in [Fig. 2A](#f2-0050073){ref-type="fig"}; sequences provided in [Table 1](#t1-0050073){ref-type="table"}). WT primers produce a 329 bp band and 'neo-out' primers produce a 415 bp band using the PCR program: for denaturing, 98°C for 30 seconds; for annealing, 60°C for 30 seconds; for extension, 72°C for 30 seconds for 39 cycles. Targeting of the R26 locus in conditional *lacZ* reporter mice, *Gt(ROSA)26Sor^tm1sor^*, was confirmed by genotyping using previously characterized primers ([@b41-0050073]) ([Table 1](#t1-0050073){ref-type="table"}). WT primers produce a 650 bp band and primers specific for the targeted locus produce a 340 bp band using the PCR conditions: for denaturing, 94°C for 30 seconds; for annealing, 62°C for 60 seconds; for extension, 72°C for 60 seconds for 34 cycles.

###### 

Primers and PCR conditions for *Noto^cre/+^* and *lacZ* reporter mice

![](DMM08128T1)

Whole-mount in situ hybridization
---------------------------------

Whole-mount in situ hybridization on E11.5 and E15.5 embryos was performed as previously described ([@b26-0050073]). Briefly, embryos were fixed at the time of collection in 4% paraformaldehyde overnight at 4°C. For hybridization, embryos were rehydrated through a MeOH/PBT \[phosphate buffered saline (PBS) plus 0.1% Tween-20 (Sigma)\] series into PBT and incubated with proteinase K (10 μg/ml in PBT) for 8 minutes at room temperature. Digestion was stopped by washing with 2 mg/ml glycine in PBT, and embryos were post-fixed in 4% paraformaldehyde with 0.2% glutaraldehyde in PBT, washed in PBT and hybridized overnight at 70°C with 1 μg/ml of digoxigenin-labeled riboprobe (Roche) in hybridization solution \[50% formamide, 5× SSC (pH 4.5), 1% SDS, 50 μg/ml yeast tRNA, and 50 μg/ml heparin\]. Embryos were washed three times in hybridization solution for 30 minutes at 70°C, rinsed three times in TNT \[10 mM Tris-HCl (pH 7.5), 0.5 M NaCl and 0.1% Tween-20\] for 5 minutes each at room temperature and incubated for 1 hour with 100 μg/ml RNase A in TNT. After three washes in 50% formamide, 2× SSC (pH 4.5), 0.5 M NaCl and 0.1% Tween-20 for 30 minutes at 65°C, followed by three washes in MAB \[100 mM maleic acid (pH 7.5), 150 mM NaCl, 2 mM levamisole and 0.1% Tween-20\] for 5 minutes at room temperature, samples were blocked for 2 hours in 10% sheep serum in MAB/2% Roche blocking agent. Embryos were incubated overnight at 4°C with anti-digoxigenin alkaline phosphatase-coupled antibody (1:5000 diluted in MAB/2% Roche block/1% sheep serum plus 0.5 mg/ml mouse embryo powder). Following MAB washes, the embryos were washed three times in NTMT \[100 mM Tris-HCl (pH 9.5), 50 mM MgCl~2~, 100 mM NaCl, and 0.1% Tween-20\] for 5 minutes each, and stained with BM Purple (Roche) at room temperature. Gene expression patterns are representative of three or more stage-matched embryos. Imaging was done on a Leica stereo light microscope with Leica Application Suite software.

Lineage tracing and β-galactosidase staining
--------------------------------------------

*Noto^cre/+^* mice were mated with *R26* conditional *lacZ* reporter mice \[Gt(ROSA)26Sor^tm1sor^ (Jackson Labs)\], so that β-galactosidase is produced upon Cre-mediated excision of STOP sequence upstream of *lacZ*. For timed matings, insemination was confirmed by vaginal sperm plug morning after coitus, which was counted as E0.5. Pregnant females were sacrificed at stated embryonic time points. Genotypic analysis of embryos was done by PCR of DNA extract, using primer sets indicated in [Table 1](#t1-0050073){ref-type="table"}. Whole-mount β-galactosidase staining was carried out using standard protocols ([@b19-0050073]). Briefly, embryos were fixed for 30 minutes (E\<13.5) or 2 hours (E\>13.5) in 0.2% glutaraldehyde/1% formaldehyde/0.02% Nonidet P-40 in PBS at room temperature. Following three washes in PBS (10 minutes each at room temperature), the embryos were incubated in X-gal staining solution \[5 mM K3Fe(CN)6/5 mM K4Fe(CN)6/2 mM MgCl2/1 mg/ml X-gal in PBS\] overnight at room temperature on rocker. Embryos were then washed with PBS 3×10 minutes at room temperature and kept in PBS overnight to allow stain to develop. Whole-mount embryos were imaged with a Nikon SMZ 1500 stereo microscope.

For visualization of β-galactosidase staining in embryos \>E15, a clearing step was performed as previously described ([@b38-0050073]). Briefly, following β-galactosidase staining embryos were cleared by a series of solutions containing decreasing KOH and increasing glycerol concentrations: 100:0, 80:20, 50:50, 20:80 and 0:100%, respectively, for 3 days each.

For analysis at P100, spine microdissection was necessary to allow for adequate stain penetration. Following β-galactosidase staining as outlined above, tissues were post-fixed in 4% formaldehyde overnight at room temperature, embedded in OCT (VWR) and sagittal sections were cut at a thickness of 10 μm.

Histology
---------

Whole embryos or postnatal spinal columns were isolated at indicated stages and fixed in 4% paraformaldehyde overnight at 4°C, dehydrated in a graded series of ethanol, cleared in xylene and embedded in paraffin. Serial sections of paraffin-embedded samples sectioned sagittally at a thickness of 5 μm were stained with 0.1% Safranin-O, 0.02% Fast Green or Harris' hematoxylin (Sigma) and Eosin-Y (Sigma).

Immunohistochemistry
--------------------

Paraffin-embedded sections were cut at a thickness of 5 μm using a microtome (Leica) and collected on Superfrost Plus slides (Fisher Scientific). Sections were then de-waxed in xylene and rehydrated by successive immersion in descending concentrations of alcohol. Samples were blocked for non-specific binding by incubating sections with the corresponding species-specific serum albumin (1%) in PBS with 0.1% Tween-20 (Sigma) for 1 hour (Sigma) and then incubated with primary antibody directed against β-galactosidase (Abcam 1:500) and cytokeratin-8 (Abcam 1:200), and then placed in a humidified chamber overnight at 4°C. After washes with PBST and incubation of goat anti-rabbit FITC and goat anti-mouse Texas Red (Jackson ImmunoResearch Laboratories; 1:500) for 90 minutes, mounting was performed with VECTASHIELD Mounting Medium with DAPI (Burlingame, CA). Images were captured with a Leica DMRA2 fluorescence microscope and processed with Northern Eclipse (Empix) software.

###### TRANSLATIONAL IMPACT

**Clinical issue**

Low back pain is a common musculoskeletal problem attributed to degeneration of the intervertebral disc (IVD) and, more specifically, the inner nucleus pulposus (NP). The lack of effective treatments is directly related to our limited understanding of the mechanisms regulating the processes of IVD development, maintenance and degeneration. To reverse the pathological process of IVD degeneration, it has been suggested that the loss of cell viability and alterations in cellular phenotype in the NP should be targeted. This approach, however, requires characterization of the developmental origins of cell types within the NP and a better understanding of the cellular phenotype of the distinct cell types responsible for maintenance of the IVD.

**Results**

To trace the developmental origins of NP cells within the IVD, the authors derive a notochord-specific Cre mouse line by targeting the homeobox transcription factor *Noto*, a gene that is expressed exclusively in the node and the posterior notochord during gastrulation. By crossing this *Noto*-*cre* mouse with a conditional *lacZ* reporter mouse, they are able to perform lineage tracing experiments to examine the contribution of the notochord to spinal development. The results show that, following formation of the axial skeleton, the notochord gives rise to the NP in the fully formed IVD. Localization of β-galactosidase, encoded by *lacZ*, demonstrates that all cells in the NP are derived from the embryonic notochord.

**Implications and future directions**

This study demonstrates that notochordal cells serve as tissue-specific stem cells within the IVD, capable of differentiating to form the NP. Further understanding of the mechanisms regulating the transition from notochord to NP cells might aid in the development of methods to induce the regeneration of NP tissue. The *Noto*-*cre* mouse described here will be a valuable tool for interrogating the function of molecules that regulate the function of notochordal cells within the IVD, with the eventual goal of identifying candidate biological treatments for disc degeneration.
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